Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 012897/0747 | |
| Pages: | 2 |
| | Recorded: | 05/10/2002 | | |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10092312
|
Filing Dt:
|
03/06/2002
|
|
Publication #:
|
|
Pub Dt:
|
07/03/2003
| | | | |
|
Title:
|
4 - (2-butylamino) - 2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-yl) pyrazolo- [1,5-A] - 1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
|
|
|
Assignee
|
|
|
|
|
| P.O. BOX 4000 |
| PATENT DEPARTMENT |
| PRINCETON, NEW JERSEY 08543 |
|
|
Correspondence name and address
|
| |
BRISTOL-MYERS SQUIBB PHARMA COMPANY
|
| |
CATHLEEN M. COLLINS
|
| |
PATENT DEPT.
|
| |
PO BOX 4000
|
| |
PRINCETON, NJ 08543-4000
|
Search Results as of:
09/22/2024 06:56 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
